Biodegradable medical adhesive and preparation method and use thereof

1. A medical adhesive comprising a mono-α-cyanoacrylate and a bis-α-cyanoacrylic acid diol ester in a weight ratio of 1:1, wherein:

1) the bis-α-cyanoacrylic acid diol ester is bis-α-cyanoacrylic acid PEG2000 ester and the mono-α-cyanoacrylate is n-butyl α-cyanoacrylate;

2) the bis-α-cyanoacrylic acid diol ester is bis-α-cyanoacrylic acid PEG2000 ester and the mono-α-cyanoacrylate is n-octyl α-cyanoacrylate; or

3) the bis-α-cyanoacrylic acid diol ester is bis-α-cyanoacrylic acid PEG600 ester and the mono-α-cyanoacrylate is n-butyl α-cyanoacrylate.

2. The medical adhesive according to claim 1 , wherein the mono-α-cyanoacrylate is n-butyl α-cyanoacrylate and the bis-α-cyanoacrylic acid diol ester is bis-α-cyanoacrylic acid PEG2000 ester.

3. The medical adhesive according to claim 1 , further comprising one or more adjuvants selected from the group consisting of

a) a plasticizer selected from the group consisting of polyethylene glycol ester, end-capped polyester, butyl stearate, lauric acid, dioctyl glutarate, triglyceride, dioctyl oxalate, triethyl phosphate, acetyl tributyl citrate, and combinations thereof;

b) a thickener selected from the group consisting of polycyanoacrylate, polylactic acid, polyglycolic acid, polycaprolactone, polyacrylic acid alkyl ester, polymethacrylic acid alkyl ester, and combinations thereof;

c) a preservative selected from the group consisting of potassium sorbate, sodium benzoate, sorbic acid, chlorocresol, and combinations thereof;

d) a coolant;

e) a fiber reinforced material selected from the group consisting of natural rubber and synthetic rubber;

f) a stabilizer including an anionic stabilizer and a free radical stabilizer, wherein the anionic stabilizer is at least one selected from the group consisting of metaphosphoric acid, maleic acid, maleic anhydride, alkyl sulfonic acid, phosphorus pentoxide, iron (III) chloride, antimony oxide, 2,4,6-trinitrophenol, thiol, alkyl sulfonyl, alkyl sulfone, alkyl sulfoxide, alkyl sulfite, sultone, sulfur dioxide, and sulfur trioxide; and the free radical stabilizer is at least one selected from the group consisting of hydroquinone, catechol and derivatives thereof;

g) a colorant selected from the group consisting of dyes and pigments, and including at least one selected from the group consisting of PGA microfibrils, collagen microfibrils, cellulose microfibrils, and olefinic microfibrils;

h) a biocompatible agent including sodium bisulfate; and

i) a polymerization or crosslinking initiator or accelerator comprising molecules including at least one selected from nucleophilic functional groups, organics and inorganics.

4. A method comprising the steps of:

uniformly mixing a mono-α-cyanoacrylate and a bis-α-cyanoacrylic acid diol ester to form a medical adhesive in which the mono-α-cyanoacrylate and the bis-α-cyanoacrylic acid diol ester are in a weight ratio of 1:1, wherein:

1) the bis-α-cyanoacrylic acid diol ester is bis-α-cyanoacrylic acid PEG2000 ester and the mono-α-cyanoacrylate is n-butyl α-cyanoacrylate;

2) the bis-α-cyanoacrylic acid diol ester is bis-α-cyanoacrylic acid PEG2000 ester and the mono-α-cyanoacrylate is n-octyl α-cyanoacrylate; or

3) the bis-α-cyanoacrylic acid diol ester is bis-α-cyanoacrylic acid PEG600 ester and the mono-α-cyanoacrylate is n-butyl α-cyanoacrylate.

5. A method according to claim 4 , further comprising placing the medical adhesive in an environment having a temperature of 4° C. or lower, and storing the medical adhesive in insulation from moisture.

6. A method according to claim 4 , further comprising contacting the medical adhesive with a wound site to be treated by smearing, spraying, or dropping the medical adhesive on the wound site.

7. A medical adhesive polymer, said medical adhesive polymer being obtained by crosslinking copolymerization of a medical adhesive under the action of anions, wherein the medical adhesive comprises a mono-α-cyanoacrylate and a bis-α-cyanoacrylic acid diol ester in a weight ratio of 1:1, wherein:

1) the bis-α-cyanoacrylic acid diol ester is bis-α-cyanoacrylic acid PEG2000 ester and the mono-αcyanoacrylate is n-butyl α-cyanoacrylate;

2) the bis-α-cyanoacrylic acid diol ester is bis-α-cyanoacrylic acid PEG2000 ester and the mono-α-cyanoacrylate is n-octyl α-cyanoacrylate; or

3) the bis-α-cyanoacrylic acid diol ester is bis-α-cyanoacrylic acid PEG600 ester and the mono-α-cyanoacrylate is n-butyl α-cyanoacrylate; and

the anions are —OH or —NH 2 in blood, body fluids, tissues, skin, or a combination thereof.

8. The medical adhesive according to claim 1 , wherein the mono-α-cyanoacrylate is n-octyl α-cyanoacrylate, and the bis-α-cyanoacrylic acid diol ester is bis-α-cyanoacrylic acid PEG2000 ester.

9. The medical adhesive according to claim 1 , further comprising one or more biological agents or therapeutic agents selected from the group consisting of anti-inflammatory analgesics, sedatives, local anesthetics, non-steroidal anti-inflammatory agents, antiallergic agents, anti-ulcer agents, antibiotics, antimicrobial agents, antiviral agents, antifungal agents, immunity inhibitors, naturally derived proteins, genetically engineered proteins, polysaccharides, glycoproteins, lipoproteins, oligonucleotides, polypeptide drugs, antibodies, antigens, chemotherapeutics, coagulant agents, hemostatic agents, coagulation factors, tissue factors, collagen, gelatin, vasopressin, plasminogen activator inhibitors, platelet activators and synthetic peptides having hemostatic activity.

10. The medical adhesive according to claim 1 , further comprising a pharmaceutically acceptable excipient.

11. The medical adhesive according to claim 1 , wherein the bis-α-cyanoacrylic acid diol ester is bis-α-cyanoacrylic acid PEG600 ester and the mono-α-cyanoacrylate is n-butylα-cyanoacrylate.